Clinical Trials Directory

Trials / Conditions / Xeroderma Pigmentosum

Xeroderma Pigmentosum

10 registered clinical trials studyying Xeroderma Pigmentosum — 2 currently recruiting.

StatusTrialSponsorPhase
Enrolling By InvitationReproductive Options in Inherited Skin Diseases
NCT06330324
Maastricht University Medical Center—
RecruitingNatural History Study for DNA Repair Disorders
NCT05484570
University of Minnesota—
UnknownA Study to Evaluate the Safety and Efficacy of Afamelanotide in Patients With Xeroderma Pigmentosum C and V
NCT05370235
Clinuvel Europe LimitedPhase 2
UnknownA Study to Evaluate the Safety and Efficacy of Afamelanotide in Patients With Xeroderma Pigmentosum (XP)
NCT05159752
Clinuvel Europe LimitedPhase 2
WithdrawnTesting the Combination of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) in Children, Adolescent, and You
NCT04500548
National Cancer Institute (NCI)Phase 1
CompletedXPAND Trial: Enhancing XP Photoprotection Activities - New Directions
NCT03445052
Guy's and St Thomas' NHS Foundation TrustN/A
UnknownXeroderma Pigmentosum Patient Experiences
NCT01123694
Henry Ford Health System—
CompletedUse of an SPF30 Sunscreen and an After-sun-lotion in Skin Cancer Risk Patients
NCT00555633
Medical University of Graz—
CompletedCancer Risk in Carriers of the Gene for Xeroderma Pigmentosum
NCT00046189
National Cancer Institute (NCI)—
CompletedExamination of Clinical and Laboratory Abnormalities in Patients With Defective DNA Repair: Xeroderma Pigmento
NCT00001813
National Cancer Institute (NCI)—